Turoctocog alfa pegol

培妥罗凝血素α

Report date: 2024/07/05 16:42:29

Base Information

Drug NameTuroctocog alfa pegol
Drug Alias NamePEG turoctocog alfa培戈-妥凝血素-8α培妥罗凝血素αRecombinant factor VIII long acting培图罗凝血素α +[18] 
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant coagulation factor
Mechanisms of ActionCoagulation factor VIII replacementsCoagulation factor X stimulantsBlood coagulation pathway activation
TargetsCoagulation factor X
Therapy Area/IndicationsHemorrhageHemophilia A
Global Approved IndicationsHemorrhageHemophilia A
Approved Indications in ChinaHemorrhageHemophilia A
Original Approved Country/TerritoryUnited States
Original Approved Date2019/02/19
Country/TerritoryBulgariaCanadaUnited States +[38] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesNovo Nordisk A/S
China Registration ClassN/A

Develop Information

Active CompaniesNovo Nordisk IncNovo Nordisk A/S
Inactive CompaniesNovo Nordisk (China)Pharmaceuticals Co LtdNovo Nordisk Pharmaceuticals
Active IndicationsHemorrhageHemophilia A
Inactive IndicationsN/A

Other Information

ATC CodeB02BD02
Related LinksDrugBankKEGG